{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:16:00Z","timestamp":1783617360643,"version":"3.55.0"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"27","license":[{"start":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T00:00:00Z","timestamp":1783036800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7,3]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>\n                      Chronic obstructive pulmonary disease (COPD) is a major public health concern due to its high prevalence, morbidity, and mortality. Although COPD is recognized as a systemic inflammatory disease, the specific circulating inflammatory proteins associated with its development and progression remain poorly understood. We performed a Mendelian randomization (MR) study to investigate the association between circulating inflammatory proteins and COPD risk. Genetic data were obtained from a genome-wide association study of 20,066 COPD cases and 338,303 controls from the FinnGen consortium and circulating inflammatory protein data were derived from a genome-wide association study of 14,824 participants. The inverse-variance weighted method was used as the primary analysis. Depending on the number of available instrumental variables, complementary methods including the Wald ratio, Weighted Median, MR-Egger, Weighted Mode, and Simple Mode were applied to assess robustness. Sensitivity analyses were conducted to evaluate heterogeneity and pleiotropy using Cochran\u2019s\n                      <jats:italic toggle=\"yes\">Q<\/jats:italic>\n                      test, the MR-Egger intercept, MR-PRESSO, and leave-one-out analysis. In addition, cis-acting protein quantitative trait locus \u2013restricted analyses were performed to further reduce potential pleiotropy. Our findings showed that higher genetically predicted levels of CCL28 (odds ratio [OR]\u2005=\u20050.83, 95% confidence interval [CI]: 0.69\u20130.99,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0394), CD40 (OR\u2005=\u20050.94, 95% CI: 0.89\u20130.99,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0170), and urokinase-type plasminogen activator (OR\u2005=\u20050.91, 95% CI: 0.85\u20130.99,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0212) were associated with a lower risk of COPD, whereas higher levels of Flt3L (OR\u2005=\u20051.09, 95% CI: 1.01\u20131.18,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0344) and CD6 (OR\u2005=\u20051.06, 95% CI: 1.02\u20131.12,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      \u2005=\u2005.0099) were associated with a higher risk. Sensitivity analyses showed no evidence of heterogeneity or directional pleiotropy, and leave-one-out analyses indicated that the results were not driven by any single nucleotide polymorphism. These findings suggest that circulating inflammatory proteins, including CCL28, CD40, urokinase-type plasminogen activator, Flt3L, and CD6, may be involved in COPD pathogenesis. Further studies are needed to validate these findings and clarify their potential biological relevance.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/md.0000000000049641","type":"journal-article","created":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T17:01:43Z","timestamp":1783098103000},"page":"e49641","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Causal effects of circulating inflammatory proteins on COPD: A Mendelian randomization study"],"prefix":"10.1097","volume":"105","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7424-3492","authenticated-orcid":false,"given":"Huanyu","family":"Long","sequence":"first","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanhe","family":"Chu","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Jiang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shurun","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Congxi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6216-0104","authenticated-orcid":false,"given":"Yahong","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Pulmonary and Critical Care Medicine, Peking University Third Hospital, Beijing, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-20260709","doi-asserted-by":"crossref","first-page":"277","DOI":"10.2478\/jtim-2022-0069","article-title":"Interpretation of the key issues of expert consensus on immunomodulatory therapies for chronic obstructive pulmonary disease.","volume":"10","author":"Sun","year":"2022","journal-title":"J Transl Internal Med"},{"key":"R3-20260709","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"R4-20260709","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-2600(20)30105-3","article-title":"Prevalence and attributable health burden of chronic respiratory diseases, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017.","volume":"8","year":"2020","journal-title":"Lancet Respir Med"},{"key":"R5-20260709","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1016\/S0140-6736(24)00367-2","article-title":"Global burden of 288 causes of death and life expectancy decomposition in 204 countries and territories and 811 subnational locations, 1990\u20132021: a systematic analysis for the Global Burden of Disease Study 2021.","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"R6-20260709","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s12916-025-04014-0","article-title":"Mapping the global distribution, risk factors, and temporal trends of COPD incidence and mortality (1990-2021): ecological analysis.","volume":"23","author":"Naeem","year":"2025","journal-title":"BMC Med"},{"key":"R7-20260709","doi-asserted-by":"crossref","first-page":"3751","DOI":"10.1038\/s41467-024-47845-w","article-title":"Genetic association of inflammatory marker GlycA with lung function and respiratory diseases.","volume":"15","author":"Guo","year":"2024","journal-title":"Nat Commun"},{"key":"R8-20260709","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1164\/rccm.202206-1066TR","article-title":"The bidirectional gut-lung axis in chronic obstructive pulmonary disease.","volume":"207","author":"Wang","year":"2023","journal-title":"Am J Respir Crit Care Med"},{"key":"R9-20260709","doi-asserted-by":"crossref","first-page":"1404615","DOI":"10.3389\/fimmu.2024.1404615","article-title":"Inflammation mechanism and research progress of COPD.","volume":"15","author":"Xu","year":"2024","journal-title":"Front Immunol"},{"key":"R10-20260709","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1038\/s41590-023-01588-w","article-title":"Genetics of circulating inflammatory proteins identifies drivers of immune-mediated disease risk and therapeutic targets.","volume":"24","author":"Zhao","year":"2023","journal-title":"Nat Immunol"},{"key":"R11-20260709","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization.","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"R12-20260709","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1001\/jama.2017.17219","article-title":"Mendelian randomization.","volume":"318","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"R13-20260709","doi-asserted-by":"crossref","first-page":"n2233","DOI":"10.1136\/bmj.n2233","article-title":"Strengthening the reporting of observational studies in epidemiology using mendelian randomisation (STROBE-MR): explanation and elaboration.","volume":"375","author":"Skrivankova","year":"2021","journal-title":"BMJ"},{"key":"R14-20260709","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population.","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"R15-20260709","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1515\/jtim-2025-0031","article-title":"Causal association between gut microbiota composition and the risk of atrial fibrillation.","volume":"13","author":"Tan","year":"2025","journal-title":"J Transl Internal Med"},{"key":"R16-20260709","doi-asserted-by":"crossref","first-page":"k601","DOI":"10.1136\/bmj.k601","article-title":"Reading Mendelian randomisation studies: a guide, glossary, and checklist for clinicians.","volume":"362","author":"Davies","year":"2018","journal-title":"BMJ"},{"key":"R17-20260709","doi-asserted-by":"crossref","first-page":"e1009922","DOI":"10.1371\/journal.pgen.1009922","article-title":"Combining the strengths of inverse-variance weighting and Egger regression in Mendelian randomization using a mixture of regressions model.","volume":"17","author":"Lin","year":"2021","journal-title":"PLoS Genet"},{"key":"R18-20260709","doi-asserted-by":"crossref","first-page":"k3788","DOI":"10.1136\/bmj.k3788","article-title":"Evaluation of the causal effects between subjective wellbeing and cardiometabolic health: Mendelian randomisation study.","volume":"362","author":"Wootton","year":"2018","journal-title":"BMJ"},{"key":"R19-20260709","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1515\/jtim-2024-0017","article-title":"Gastroesophageal reflux disease influences blood pressure components, lipid profile and cardiovascular diseases: evidence from a Mendelian randomization study.","volume":"12","author":"Wu","year":"2024","journal-title":"J Transl Internal Med"},{"key":"R20-20260709","doi-asserted-by":"crossref","first-page":"a038984","DOI":"10.1101\/cshperspect.a038984","article-title":"Multivariable Mendelian randomization and mediation.","volume":"11","author":"Sanderson","year":"2021","journal-title":"Cold Spring Harb Perspect Med"},{"key":"R21-20260709","doi-asserted-by":"crossref","first-page":"17510","DOI":"10.3390\/ijms242417510","article-title":"CD6 and its interacting partners: newcomers to the block of cancer immunotherapies.","volume":"24","author":"Arag\u00f3n-Serrano","year":"2023","journal-title":"Int J Mol Sci"},{"key":"R22-20260709","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/cells9122589","article-title":"Soluble CD5 and CD6: lymphocytic class I scavenger receptors as immunotherapeutic agents.","volume":"9","author":"Velasco-de Andr\u00e9s","year":"2020","journal-title":"Cells"},{"key":"R23-20260709","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3390\/cells14040272","article-title":"CD6 in human disease.","volume":"14","author":"Gurrea-Rubio","year":"2025","journal-title":"Cells"},{"key":"R24-20260709","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1007\/s10238-023-01192-0","article-title":"M\u00e9ni\u00e8re\u2019s disease and allergy: epidemiology, pathogenesis, and therapy.","volume":"23","author":"Xu","year":"2023","journal-title":"Clin Exp Med"},{"key":"R25-20260709","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1016\/j.ajpath.2017.08.016","article-title":"Constitutive CD40 signaling in dendritic cells limits atherosclerosis by provoking inflammatory bowel disease and ensuing cholesterol malabsorption.","volume":"187","author":"Kusters","year":"2017","journal-title":"Am J Pathol"},{"key":"R26-20260709","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.cyto.2018.09.005","article-title":"Serum cytokine profiles in patients with chronic obstructive pulmonary disease associated pulmonary hypertension identified using protein array.","volume":"111","author":"Zhang","year":"2018","journal-title":"Cytokine"},{"key":"R27-20260709","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/j.immuni.2021.01.012","article-title":"Chemokines and the immune response to cancer.","volume":"54","author":"Ozga","year":"2021","journal-title":"Immunity"},{"key":"R28-20260709","doi-asserted-by":"crossref","first-page":"1176619","DOI":"10.3389\/fimmu.2023.1176619","article-title":"The chemokine landscape: one system multiple shades.","volume":"14","author":"Cecchinato","year":"2023","journal-title":"Front Immunol"},{"key":"R29-20260709","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.intimp.2017.08.012","article-title":"CCL28 chemokine: an anchoring point bridging innate and adaptive immunity.","volume":"51","author":"Mohan","year":"2017","journal-title":"Int Immunopharmacol"},{"key":"R30-20260709","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1038\/s41423-023-01032-x","article-title":"New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine.","volume":"20","author":"Xu","year":"2023","journal-title":"Cell Mol Immunol"},{"key":"R31-20260709","doi-asserted-by":"crossref","first-page":"e37","DOI":"10.1017\/erm.2022.28","article-title":"Roles of CCR10\/CCL27-CCL28 axis in tumour development: mechanisms, diagnostic and therapeutic approaches, and perspectives.","volume":"24","author":"Mergia Terefe","year":"2022","journal-title":"Expert Rev Mol Med"},{"key":"R32-20260709","doi-asserted-by":"crossref","first-page":"2404","DOI":"10.4103\/1673-5374.338991","article-title":"The uPA\/uPAR system in astrocytic wound healing.","volume":"17","author":"Yepes","year":"2022","journal-title":"Neural Regen Res"},{"key":"R33-20260709","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.ymthe.2025.01.032","article-title":"Vitronectin regulates lung tissue remodeling and emphysema in chronic obstructive pulmonary disease.","volume":"33","author":"Liu","year":"2025","journal-title":"Mol Ther"},{"key":"R34-20260709","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1007\/s00408-019-00211-w","article-title":"Soluble urokinase-type plasminogen activator receptor and arterial stiffness in patients with COPD.","volume":"197","author":"B\u00f6cskei","year":"2019","journal-title":"Lung"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049641","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T17:02:39Z","timestamp":1783616559000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000049641"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,3]]},"references-count":33,"journal-issue":{"issue":"27","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000049641","relation":{},"ISSN":["0025-7974","1536-5964"],"issn-type":[{"value":"0025-7974","type":"print"},{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,3]]},"assertion":[{"value":"2025-10-20","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-06-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}